Oral Contraceptive Use, Micronutrient Deficiency, and Obesity among Premenopausal Females in Korea: The Necessity of Dietary Supplements and Food Intake Improvement by ���������
RESEARCH ARTICLE
Oral Contraceptive Use, Micronutrient
Deficiency, and Obesity among
Premenopausal Females in Korea: The
Necessity of Dietary Supplements and Food
Intake Improvement
Boyoung Park1,2, Jeongseon Kim1,3*
1 Department of Cancer Control and Policy, Graduate School of Cancer Science and Policy, National
Cancer Center, Goyang-si, Korea, 2 Cancer Early Detection Branch, Division of Cancer Management Policy,
National Cancer Control Institute, National Cancer Center, Goyang-si, Korea, 3 Molecular Epidemiology




This study addressed the associations between oral contraceptive (OC) use and obesity as
measured by recording the body mass index (BMI) of premenopausal females, and possible
interactions with micronutrient intake were considered. A group of 39,189 premenopausal
females aged 35–59 were included in the analysis; they were in the Health Examinee
cohort. Participant BMIs were calculated from anthropometric measurements, and females
with a BMI25kg/m2 were considered obese. Individual OC use, age at first OC use, dura-
tion of OC use, nutrient intake, and other covariates were measured with a structured ques-
tionnaire. A multivariate logistic regression with an interaction term was applied to identify
the odds ratio (OR) and 95% confidence intervals (CI) between OC use and obesity along
with consideration of micronutrient intake interactions. OC use is associated with an
increased risk of obesity (OR = 1.12, 95% CI = 1.04–1.20), and females who used OCs for
more than 6 months over their lifetimes were more likely to be obese (OR = 1.15, 95% CI =
1.01–1.32) compared with those who used OCs for <6 months. There were interaction
effects between phosphorus, potassium, vitamin A, vitamin B1, vitamin B2, niacin, vitamin C
intake and total duration of OC use on being obesity (P-value<0.05). When stratified by
micronutrient intake, the associations between total OC use duration and obesity were pres-
ent only among those with calcium, phosphorus, potassium, vitamin A, B1, B2, C, niacin,
and folate intakes below the recommended levels. Efforts to estimate nutrient intake and
prevent micronutrient depletion with supplements or food should be considered by clinicians
for females who take OC for a long period.
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Introduction
Contraception use by females in their childbearing years and the choice of having safe, effec-
tive, affordable and acceptable contraceptive methods as part of family planning are important
dimensions of reproductive health. Oral contraceptives (OCs) are currently the most com-
monly used contraception method in developed countries. In developing countries, female
sterilization and intrauterine devices are the two most commonly used contraceptive methods,
accounting for 58% of all contraceptive use [1]. However, in developed countries in Asia such
as Japan and the Republic of Korea, the prevalence of OC use is lower than it is in other West-
ern countries [1], suggesting that there are different preferred methods depending on the
region.
In Western countries, adherence to OC use is poor, with a 6-month discontinuation rate of
more than 50% [2, 3]; side effects are the most common reason for poor compliance [2, 4, 5].
Although previous longitudinal studies and randomized controlled trials have shown that OCs
do not have an effect on weight change [6, 7], and a recent review by Cochrane suggested that
OC use did not significantly affect weight [8], weight gain is frequently reported as a side effect
of OC use [9]. The OC discontinuation rate among the females who gained weight from OCs
was 40% higher compared to the females who did not gain weight [2].
Another potential effect of OC use is higher micronutrient requirements. Females who used
OCs showed lower blood nutrient levels compared with non-users, suggesting that they may
need higher amounts of vitamins and minerals. In addition, an association between micronu-
trient deficiencies and obesity has been suggested to occur via changes in leptin concentrations
or increases in the inflammatory response [10–13]. Therefore, OC use and micronutrient defi-
ciency and micronutrient deficiency and obesity are correlated, and interplay between OC use
and micronutrient intake in the effect on obesity seems plausible.
In this study, we investigated possible associations between OC use and obesity as measured
by recording the body mass indexes (BMI) of premenopausal females in health examinee-
based samples in Korea. In particular, the possible interactions between OC use and micronu-
trient intake in association with obesity were examined.
Materials and Methods
Data source and study population
Data from the Health Examinee (HEXA) cohort was part of the Korea Genome Epidemiology
Study (KoGES), which is an ongoing cohort study that was started in 2001 to investigate the
effects of various factors and their interactions on the development of chronic diseases in the
Korean population, and it was used in this study. Health examinees from health examination
centers in 14 urban areas around Korea were recruited from 2004–2013, and the baseline sur-
vey and measurement information was analyzed. The interviewers gave information about the
HEXA cohort, and informed consents were obtained from health examinees who agreed to
participate. All participants completed a questionnaire including their past medical history,
sociodemographic and behavioral characteristics, reproductive factors, and a validated food
frequency questionnaire, which assessed the intake of 106 food items, was administered by the
interviewers. Daily nutrient intake was estimated using the sum of the nutrient intake of each
food item [14, 15]. In addition, information from physical examinations including anthropo-
metric measurements and biochemical measurements with a fasting blood sample that was
part of a routine process was obtained from all participants. Details of the KoGES and HEXA
cohort are described elsewhere [16] or at the Korea National Institute of Health website (http://
www.nih.go.kr/NIH/eng/main.jsp).
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Among the 111,592 female participants aged 35–73, 62,640 had stopped menstruating for
more than 12 months, 2,716 had stopped menstruating for approximately 3 months, 9,440
were premenopausal with an irregular cycle, 30,004 were premenopausal with a regular cycle,
and 6,792 had missing information about their menstruation. Among the 39,444 premeno-
pausal females, 39,189 females under 60 were included in the analysis. The Institutional Review
Board of the National Cancer Center approved this study protocol, which was in compliance
with the Declaration of Helsinki (IRB No: NCC2014-0098).
Variables
For the obesity index, participant BMIs were calculated as weight (kg)/height2 (m2) by using
anthropometric measurements, and females with a BMI25 kg/m2 were considered obese
according to the World Health Organization’s revised guidelines for Asians [17, 18]. Individual
OC use, age at first OC use, and duration of OC use were assessed by a questionnaire. OC use
was categorized as never use and use. The age at first OC use and the total duration of OC use
were used to calculate the median (<28 years old and28 years old) or quartile values
(<3months, 3–6 months, 6–12 months, and>12 months) in the premenopausal females
included in this study. The other covariates included age (in 1 year increments), smoking status
(never, ex-smoker, or current smoker), drinking status (never, ex-drinker, or current drinker),
regular exercise (none,< 150 minutes/week, or 150 minutes/week) based on current Europe
[19], and World Health Organization physical activity guidelines [20], educational attainment
(< high school, college), monthly household income (<$3000/month,$3000/month),
marital status (married, single/divorced/widowed), occupation (unemployed/housewife, white
collar job, blue collar job), parity (nulliparous, 1–2, 3 or more), and total energy intake (kcal/
day,<1400, 1400–1699, 1700–2049, 2050 as quartile in the included subjects).
Among the assessed nutrients, we included calcium, phosphorus, potassium, vitamin A,
vitamin B1, vitamin B2, niacin, vitamin C and folate because the recommended daily intake
level or adequate intake level of these nutrients have been identified for Koreans.
Statistical analysis
The sociodemographic and health behavioral characteristics of those who never used OCs and
those who did were compared by using a chi-square test or a t-test. To identify the association
between OC use and obesity, we conducted a multivariate logistic regression analysis to esti-
mate the odds ratios (ORs) and 95% confidence intervals (CI) by OC use, age at first OC use,
and duration of OC use, and the values were adjusted for age, smoking status, drinking status,
regular exercise, educational attainment, monthly household income, marital status, occupa-
tion, parity, and total energy intake.
To identify the interaction effects between age of first OC use, duration of OC use and
micronutrient intake in association with obesity, the interactions were assessed by using multi-
variate logistic regression with interaction terms. In addition, the association between the age
at first OC use, the duration of OC use and obesity was stratified by micronutrient intake (less
than recommended level, recommended level or more). All statistical analyses were performed
with SAS software ver. 9.1 (SAS Institute, Cary, NC, USA).
Results
Of the 39,189 females, 5,508 (16.1%) had some experience in using OC including 5,291 past
users and 217 current users. The sociodemographic and health behavioral characteristics of
people who used OCs and those who never did are shown in Table 1. The females who took
OCs were older and had lower rates of education beyond high school, increased tobacco or
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Table 1. Comparison of basic characteristics between oral contraceptive users and nonusers.
Characteristics Nonusers (n = 33681) Oral contraceptive users (n = 5508) P-value a
n (%) n (%)
Age, mean (95% CI) 45.0(44.9–45.0) 45.4 (45.3–45.5) <0.001
Smoking status
Never 32323 (96.0) 5046 (91.6) <0.001
Ex-smoker 405 (1.2) 156 (2.8)
Current smoker 799 (2.4) 281 (5.1)
Missing 154 (0.5) 25 (0.5)
Drinking status
Never 19291 (57.3) 2612 (47.4) <0.001
Ex-drinker 692 (2.1) 161 (2.9)
Current drinker 13610 (40.4) 2720 (49.4)
Missing 88 (0.3) 15 (0.3)
Regular exercise
No 17610 (52.3) 2844 (51.6) 0.020
< 150 minutes/week 4223 (12.5) 704 (12.8)
 150 minutes/week 10912 (32.4) 1766 (32.1)
Missing 936 (2.8) 194 (3.5)
Educational attainment
< High school 20532 (61.0) 3983 (72.3) <0.001
 College 12882 (38.2) 1458 (26.5)
Missing 267 (0.8) 67 (1.2)
Household income
< $3000/month 12137 (36.0) 2322 (42.2) <0.001
 $3000/month 18088 (53.7) 2487 (45.1)
Missing 3456 (10.3) 699 (12.7)
Marital status
Single, divorced, widow 3215 (9.5) 684 (12.4) <0.001
Married 30400 (90.3) 4808 (87.3)
Missing 66(0.2) 16 (0.3)
Occupation
Unemployed, housewife 16383 (48.6) 2677 (48.6) <0.001
White color job 7437 (22.1) 891 (16.2)
Blue color job 9385 (27.9) 1861 (33.8)
Missing 476 (1.4) 79 (1.4)
Parity
Nullipara 402 (1.2) 119 (2.2) <0.001
1–2 26821 (79.5) 4382 (79.6)
 3 4759 (14.1) 865 (15.7)
Missing 1699 (5.0) 142 (2.5)
Energy intake (kcal/day)
<1400 8440 (25.1) 1460 (26.5) 0.076
1400–1699 8073 (24.0) 1263 (22.9)
1700–2049 8479 (25.2) 1344 (24.4)
 2050 8363 (24.8) 1379 (25.0)
Missing 326 (1.0) 62 (1.1)
Body mass index (kg/m2)
< 25 26214 (77.8) 4097 (74.4) <0.001
(Continued)
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alcohol use and engaged in exercise less regularly. They reported lower household incomes,
and being unmarried. They were more likely to be engaged in blue collar work. The proportion
of obese females was higher in OC users (21.8% in never-users compared with 25.2% in users,
P-value<0.001). There were no significant differences in energy intake distribution between
the two groups. Among the OC users, the median age at first OC use was 28 years old and the
quartile ranges for the duration of OC use were<3 months, 3–6 months, 6–12 months and
>12 months.
OC use in females was associated with obesity (OR = 1.12, 95% CI = 1.04–1.20). In addition,
age increment, being engaged in blue collar work, higher parity, and higher energy intake were
associated with increased obesity, while regular exercise and higher educational attainment and
household income decreased the odds of being obese (Table 2).
Among the OC users, age at first OC use was not significantly associated with obesity. How-
ever, those who used OCs for longer periods showed an independent increased association
with obesity (OR = 1.22, 95%, CI = 1.02–1.46 for those who used OCs for 3–6 months;
OR = 1.22, 95%, CI = 1.01–1.48 for those used OCs for 6–12 months, compared with those
who used OCs for less than 3 months), although the results for participants who used OCs for
more than 12 months were not significant (Table 3). When applied median value, females who
used OCs for 6 months or more were more likely to be obese (OR = 1.15, 95%, CI = 1.01–1.32)
compared with those who used OC<6 months (data not shown).
In addition, there were significant interaction effects between phosphorus, potassium,
vitamin A, B1, B2, C, niacin intake and total duration of OC use (P-interaction = 0.044, 0.001,
0.012, 0.027, 0.034, 0.038, and 0.003, respectively. See Table 4). The analyses that were strati-
fied by micronutrient intake showed that OC intake for 3 months or more increased the odds
of being obese among those whose intakes of calcium, phosphorus, potassium, vitamin A,
vitamin B1, vitamin B2, niacin, vitamin C, and folate were lower than the recommended lev-
els, yielding odds ratios ranging from 1.22 to 1.70 (Table 4). For those consuming more than
the recommended levels of these nutrients, the duration of OC use was not associated with
obesity.
Table 1. (Continued)
Characteristics Nonusers (n = 33681) Oral contraceptive users (n = 5508) P-value a
n (%) n (%)
 25 7338 (21.8) 1390 (25.2)
Missing 129 (0.4) 21 (0.4)
Age at ﬁrst OC use
<28 - 2607 (47.3)
28 - 2172 (39.4)
Missing - 729 (13.3)
Total duration of OC use (months)
<3 months - 1572 (28.5)
3–6 months - 1187 (21.6)
6–12 months - 987 (17.9)
>12 months - 1741 (31.6)
Missing - 21 (0.4)
a Chi-square test or t-test results
CI: conﬁdence intervals; OC: oral contraceptives
doi:10.1371/journal.pone.0158177.t001
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Table 2. Multivariate logistic regression for the associated factors with obesity (bodymass index25kg/m2).
BMI<25kg/m BMI> = 25kg/m2 OR (95% CI) a
n (%) n (%)
Age
1 year increment, mean (SD) 44.9 (4.1) 45.6 (4.2) 1.03 (1.03–1.04)
Smoking status
Never 28094 (95.8) 8323 (95.8) 1
Ex-smoker 427 (1.4) 130 (1.5) 1.13 (0.92–1.39)
Current smoker 839 (2.8) 238 (2.7) 0.96 (0.82–1.11)
Drinking status
Never 16913 (56.0) 4901 (56.3) 1
Ex-drinker 641 (2.1) 206 (2.4) 1.13 (0.96–1.33)
Current drinker 12672 (41.9) 3603 (41.4) 1.00 (0.95–1.05)
Regular exercise
No 15629 (53.1) 4745 (55.9) 1
< 150 minutes/week 3856 (13.1) 1050 (12.4) 0.92 (0.85–0.99)
 150 minutes/week 9949 (33.8) 2690 (31.7) 0.87 (0.83–0.93)
Educational attainment, N (%)
< High school 18137 (60.3) 6307 (73.1) 1
 College 11939 (39.7) 2325 (26.9) 0.67 (0.63–0.71)
Monthly household income, N (%)
<$3000/month 10689 (39.3) 3740 (48.6) 1
$3000/month 16535 (60.7) 3958 (51.4) 0.79 (0.75–0.83)
Marital status
Married 3007 (9.9) 875 (10.0) 1
Single, divorced, widow 27240 (90.1) 7836 (90.0) 1.01 (0.92–1.11)
Occupation
Unemployed, housewife 14730 (49.3) 4255 (49.5) 1
White color job 6834 (22.9) 1450 (16.9) 0.95 (0.89–1.02)
Blue color job 8336 (27.9) 2883 (33.6) 1.08 (1.02–1.14)
Parity
Nullipara 433 (1.5) 88 (1.1) 1
1–2 24358 (84.6) 6727 (80.1) 1.30 (1.03–1.65)
 3 4017 (13.9) 1585 (18.9) 1.70 (1.34–2.17)
Energy intake (kcal/day)
<1400 7842 (26.1) 2024 (23.5) 1
1400–1699 7257 (24.2) 2045 (23.7) 1.11 (1.03–1.19)
1700–2049 7599 (25.3) 2187 (25.4) 1.16 (1.08–1.24)
 2050 7341 (24.4) 2366 (27.4) 1.33 (1.24–1.42)
Oral contraceptive use
Never 26214 (86.5) 7338 (84.1) 1
Ever 4097 (13.5) 1390 (15.9) 1.12 (1.04–1.20)
CI: Standard deviation
a Adjusted for age, smoking status, drinking status, regular exercise, educational attainment, monthly household income, marital status, parity, occupation,
and energy intake
doi:10.1371/journal.pone.0158177.t002
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Discussion
This study employed baseline information to show that premenopausal females who used OCs
had 12% higher odds of being obese, and among OC users, OC use duration of more than 3
months had a positive association with obesity. However, when stratified by micronutrient
intake, OC use of more than 3 months had a positive association with obesity among females
whose micronutrient intake was not sufficient. For those who took in more than recom-
mended, the duration of OC use was not associated with being obese. Although this study
design did not allow for causal inference, the findings suggested that consuming adequate levels
of micronutrients may be necessary for OC users, who may also face higher odds of obesity.
Although a direct comparison with previous clinical trials that showed OC use did not affect
weight change [6–8] might be difficult, our results showed that OC users had an increased ten-
dency to be obese after controlling for the effects of other factors. Although the distribution of
energy intake was not different, OC users exhibited more unhealthy behaviors and lower socio-
economic characteristics, such as smoking, drinking, completing less education, earning lower
incomes, being unmarried and working a blue collar job. Thus, differences in unmeasured
covariates and health behaviors between OC users and non-users may increase the odds of obe-
sity in OC users. Otherwise, the effect of OCs may be different according to regions or ethnici-
ties when considering that all previous clinical trials included in the Cochrane review were
conducted in Western countries, and there was no Asian study included. To identify the causal
association, we suggest that future studies target females living in Asia where OC use is not a
common contraceptive method.
Several review studies have shown that blood folate, vitamin B2, vitamin B6, vitamin B12,
vitamin C, vitamin E, zinc, selenium, and magnesium was lower in OC users in comparison
with non-users [13, 21]. It is well-known that nutrient deficiencies in antioxidants, vitamin A,
vitamin B complex, vitamin D, calcium, iron, and zinc have been associated with obesity [10,
22]. These deficiencies included low serum levels or lower intake [10]. The increased intake of
calcium prevents fatty acid synthesis and promotes lipolysis and lipid oxidation [10, 23]; phos-
phorus consumption from food compromises adenosine triphosphate production, which regu-
lates energy metabolism and regulates insulin release [24]; vitamin A inhibits adipogenesis,
increases fat cell apoptosis, and regulates leptin [10, 25–27]; and vitamin C, an antioxidant, reg-
ulates gene expression involved in adipogenesis and glucocorticoid metabolism [10]. Although
a direct mechanism linking potassium, B vitamins and obesity is not evident, lower potassium
consumption induces insulin resistance and increases metabolic syndrome [28], and several
Table 3. Associations between age at first OC use, duration of oral contraceptives use and obesity
(bodymass index25kg/m2) in ever-oral contraceptive users.
OR (95% CI) a P-value
Age at ﬁrst oral contraceptives use
<28 1
28 0.99 (0.87–1.14) 0.915
Total duration of oral contraceptives use
<3 months 1
3–6 months 1.22 (1.02–1.46) 0.031
6–12 months 1.22 (1.01–1.48) 0.036
>12 months 1.15 (0.96–1.34) 0.133
a Adjusted for age, smoking status, drinking status, regular exercise, educational attainment, monthly
household income, marital status, parity, occupation, and energy intake
doi:10.1371/journal.pone.0158177.t003
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Table 4. Associations between age at first oral contraceptives use, duration of oral contraceptives use and obesity (bodymass index25kg/m2)
in ever-oral contraceptive users, stratified by micronutrient intake.
P-interaction Lower than required value Upper than required value
OR (95% CI) a OR (95% CI) a
Age at ﬁrst oral contraceptives use
Calcium intake
<28 0.475 1 1
28 0.99 (0.85–1.14) 1.05 (0.72–1.52)
Phosphorus intake
<28 0.820 1 1
28 1.01 (0.86–1.18) 0.95 (0.73–1.22)
Potassium intake
<28 0.078 1 1
28 0.95 (0.82–1.10) 1.27 (0.87–1.85)
Vitamin A intake
<28 0.839 1 1
28 1.01 (0.86–1.18) 0.95 (0.72–1.26)
Vitamin B1 intake
<28 0.385 1 1
28 1.06 (0.89–1.26) 0.91 (0.73–1.12)
Vitamin B2 intake
<28 0.475 1 1
28 1.03 (0.88–1.21) 0.90 (0.68–1.18)
Niacin intake
<28 0.352 1 1
28 0.94 (0.77–1.14) 1.04 (0.86–1.26)
Vitamin C intake
<28 0.219 1 1
28 0.93 (0.77–1.14) 1.08 (0.89–1.31)
Folate intake
<28 0.582 1 1
28 0.98 (0.85–1.14) 1.06 (0.67–1.68)
Total duration of oral contraceptives use
Calcium intake
<3 months 0.083 1 1
3–6 months 1.23 (1.01–1.49) 1.05 (0.65–1.70)
6–12 months 1.30 (1.06–1.59) 0.79 (0.46–1.36)
>12 months 1.24 (1.04–1.48) 0.79 (0.50–1.24)
Phosphorus intake
<3 months 0.044 1 1
3–6 months 1.26 (1.01–1.56) 1.12 (0.80–1.57)
6–12 months 1.44 (1.16–1.80) 0.80 (0.55–1.15)
>12 months 1.22 (1.10–1.49) 1.02 (0.75–1.39)
Potassium intake
<3 months 0.001 1 1
3–6 months 1.29 (1.06–1.57) 0.83 (0.56–1.18)
6–12 months 1.41 (1.15–1.73) 0.42 (0.23–0.74)
>12 months 1.25 (1.04–1.49) 0.75 (0.49–1.17)
Vitamin A intake
(Continued)
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previous studies have shown lower levels of B vitamins in obese people [10]. Considering that
OC use may increase micronutrient intake requirements [13], the relationships among total
duration of OC use and micronutrient intake in association with obesity observed in this study
may be related to unmet micronutrient needs, an intermediately associated factor in the rela-
tionship between longer OC use and obesity. In addition, we did not observe significant associ-
ations for longer duration OC use among those who ingested micronutrients above the
recommended levels. No significant interplay between age at which OCs were started and
micronutrient intake on the associations with obesity was observed, suggesting an interaction
between cumulative exposure to OCs and higher micronutrient requirements, which may be
associated with obesity. Although we adjusted for possible confounding variables, further pro-
spective studies are necessary to understand whether these interactions are causal.
As the authors acknowledge, this is the first study to investigate possible interactions
between OC use and micronutrient intake, and the major limitation of this study should be
Table 4. (Continued)
P-interaction Lower than required value Upper than required value
OR (95% CI) a OR (95% CI) a
<3 months 0.012 1 1
3–6 months 1.34 (1.09–1.65) 0.95 (0.65–1.37)
6–12 months 1.42 (1.14–1.76) 0.76 (0.51–1.12)
>12 months 1.33 (1.10–1.61) 0.75 (0.54–1.05)
Vitamin B1 intake
<3 months 0.027 1 1
3–6 months 1.49 (1.17–1.88) 0.95 (0.72–1.27)
6–12 months 1.51 (1.18–1.92) 0.91 (0.67–1.23)
>12 months 1.31 (1.06–1.62) 0.99 (0.77–1.29)
Vitamin B2 intake
<3 months 0.034 1 1
3–6 months 1.34 (1.09–1.65) 0.91 (0.63–1.31)
6–12 months 1.39 (1.12–1.73) 0.83 (0.56–1.22)
>12 months 1.30 (1.07–1.56) 0.82 (0.59–1.15)
Niacin intake
<3 months 0.003 1 1
3–6 months 1.70 (1.31–2.22) 0.94 (0.74–1.21)
6–12 months 1.69 (1.28–2.23) 0.93 (0.72–1.20)
>12 months 1.36 (1.07–1.73) 1.05 (0.84–1.31)
Vitamin C intake
<3 months 0.038 1 1
3–6 months 1.38 (1.06–1.81) 1.96 (0.85–1.39)
6–12 months 1.64 (1.26–2.15) 0.92 (0.70–1.20)
>12 months 1.33 (1.05–1.69) 1.04 (0.83–1.30)
Folate intake
<3 months 0.161 1 1
3–6 months 1.27 (1.06–1.54) 0.76 (0.41–1.42)
6–12 months 1.29 (1.06–1.66) 0.68 (0.34–1.35)
>12 months 1.22 (1.03–1.45) 0.69 (0.39–1.20)
a Adjusted for age, smoking status, drinking status, regular exercise, educational attainment, monthly household income, marital status, parity, occupation,
and energy intake
doi:10.1371/journal.pone.0158177.t004
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mentioned. This study employed a baseline survey along with measurements from premeno-
pausal females who visited health examination centers, and it used a cross-sectional approach
that has an important limitation in the interpretation of causal relations between exposure and
outcome. However, it seems unlikely that obesity could be the determinant of OC use, and obe-
sity was measured at the time of study recruitment; OC use reflected both past and current
exposure, by including both current and past users. The number of current OC users was too
small (217 of 39,189, 0.55%), and thus we could not observe the current OC use effect on obe-
sity. The study subjects were health examinees who went for health check-ups and agreed to
participate in the HEXA cohort study. Although the Korean government offers various health
screenings to the whole population for free or at low cost to increase accessibility, the partici-
pants might be more concerned about their health status than populations who did not receive
health examinations. Thus, the generalization of our results to all premenopausal females who
ever used OCs should be treated with caution. The prevalence of current OC use among mar-
ried women aged 15–44 was 2.3% in Korea [29], which was higher than our results (0.55%),
but the marital status and age distribution of these two populations were not different, and
therefore, a direct comparison might be not possible. Following the 1990s, most OCs in use
have been a combination of estrogens and progestins, and a few might contain estrogen alone
or progesterone only, but component information was not available. Information on heights
and weights was taken by trained health center workers, but OC use and nutrient intake were
obtained with questionnaires. Although there is a possibility of some recall bias, misclassifica-
tion of OC use may not be systematic because we used the baseline information from the
cohort study, which is less affected by recall bias [30], and its influence over the true effect
would be minimal. The validated food frequency questionnaire, which covered food items that
are generally consumed by Koreans [14], was applied for nutrient intake, and thus a bias caused
by the nutrition intake measurement also would not be serious. We could not determine
whether the source of the nutrients was from food or dietary supplements because daily nutri-
ent intake was calculated using the sum of the nutrient intake for each food item and was not
divided by the intake source. We tried to control for the effects of other covariates through
multivariate adjustment, but residual confusion from uncontrolled variables would remain.
For example, polycystic ovarian syndrome, which has a prevalence in Korean females of 4–6%
[31, 32] could be a confounding factor by possibly increasing obesity and OC intake [33]; how-
ever, neither the questionnaire nor medical examination assessed each subject’s history of poly-
cystic ovarian syndrome.
Despite these limitations, the strength of this study is that it includes a large number of sub-
jects with a sufficient number of females who have used OCs. Considering the lower prevalence
of OC use in Asian females [1], a large study population is needed to obtain enough OC users.
Because all the participants were health examinees, we expect that they would have relatively
homogenous characteristics compared with population-based samples, and the comparability
of the study population would be increased.
In conclusion, females who have taken OCs had higher odds of obesity than never-users,
and those who took OC for 3 months or more over their lifetimes had an increased association
with obesity. However, the association between total duration of OC use of 3 months or more
and obesity was modified by micronutrient intake, and it was only present among those whose
micronutrient intakes were below the recommended levels. Considering that these micronutri-
ents play a role not only in obesity but also in many functions used to regulate our multiple
metabolic pathways, efforts to increase micronutrient intake should be considered for females
taking OCs. Future clinical trials may confirm the effects of the interaction between cumulative
OC use and micronutrient intake on obesity, and given the results of this study, dietary
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recommendations to ensure sufficient micronutrient intake should be considered by clinicians
for those who take OCs for longer periods.
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